Non-Squamous Non-Small Cell Lung Cancer Completed Phase 4 Trials for Erlotinib (DB00530)

Also known as: Non-squamous Non-small Cell Lung Cancer

IndicationStatusPhase
DBCOND0036730 (Non-Squamous Non-Small Cell Lung Cancer)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01066884A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT01609543A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR MutationsTreatment